Cargando…
Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes
Development of the 4-component meningococcal serogroup B vaccine (4CMenB) has required new assays for the reliable evaluation of the expression and cross-reactivity of those specific antigen variants that are predicted to be targeted by bactericidal antibodies elicited by the vaccine in different is...
Autores principales: | Domnich, Alexander, Gasparini, Roberto, Amicizia, Daniela, Boccadifuoco, Giuseppe, Giuliani, Marzia Monica, Panatto, Donatella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553328/ https://www.ncbi.nlm.nih.gov/pubmed/26351645 http://dx.doi.org/10.1155/2015/353461 |
Ejemplares similares
-
New versus old meningococcal Group B vaccines: How the new ones may benefit infants & toddlers
por: Panatto, D., et al.
Publicado: (2013) -
Meningococcal B vaccination strategies
and their practical application in Italy
por: GASPARINI, R., et al.
Publicado: (2015) -
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis
por: Gasparini, Roberto, et al.
Publicado: (2016) -
Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975) -
Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine
por: Tsang, Raymond S. W., et al.
Publicado: (2020)